The Apheresis Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Devices, Disposables), By Procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Others), By Technology (Centrifugation, Membrane Separation), By Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, Others).
Apheresis, also known as therapeutic apheresis or extracorporeal therapy, is a specialized medical procedure that involves separating blood components and selectively removing certain substances from the bloodstream. In 2024, apheresis techniques encompass a variety of modalities, including plasma exchange, leukapheresis, and erythrocytapheresis, each tailored to target specific therapeutic goals, such as removing toxins, managing autoimmune disorders, or collecting blood components for transfusion. By utilizing centrifugation or filtration methods, apheresis procedures enable clinicians to selectively remove pathogenic substances, abnormal cells, or excess plasma components from the blood while returning the remaining blood components to the patient. With applications spanning hematology, nephrology, neurology, and transplantation medicine, apheresis plays a critical role in treating a diverse range of acute and chronic conditions, offering patients life-saving therapies and symptom relief.
One prominent trend in the apheresis market is the increasing demand for therapeutic apheresis procedures. Therapeutic apheresis, also known as therapeutic plasma exchange or plasmapheresis, involves the extracorporeal removal, manipulation, or exchange of blood components to treat various medical conditions, including autoimmune disorders, neurological diseases, hematological disorders, and transplant-related complications. This trend is driven by advancements in apheresis technology, expanding indications for therapeutic apheresis, and the growing awareness among healthcare providers about the efficacy of apheresis as a therapeutic intervention. As more clinical evidence supports the use of therapeutic apheresis in managing a diverse range of diseases, there is a rising demand for apheresis systems, consumables, and services to meet the needs of patients and healthcare facilities worldwide.
A significant driver in the apheresis market is the rising incidence of chronic and autoimmune diseases. The increasing prevalence of autoimmune disorders, such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus, as well as hematological conditions like thrombotic thrombocytopenic purpura (TTP) and myasthenia gravis, fuels the demand for therapeutic apheresis as a treatment modality. Additionally, the growing number of solid organ and stem cell transplant procedures performed globally has led to an increased need for apheresis-based therapies to manage transplant-related complications, including graft-versus-host disease and antibody-mediated rejection. The rising burden of chronic and autoimmune diseases, coupled with advancements in apheresis technology and clinical protocols, drives the adoption of therapeutic apheresis as a vital component of comprehensive disease management strategies, propelling the market growth.
An emerging opportunity in the apheresis market is the expansion into emerging applications and market segments. While therapeutic apheresis has traditionally been used to treat autoimmune disorders, hematological diseases, and transplant-related complications, there is potential to explore new therapeutic indications and market segments for apheresis-based therapies. This includes applications in neurology, oncology, hematology, and critical care, where apheresis procedures have shown promise in managing neurological conditions, removing circulating tumor cells, and treating acute complications such as cytokine storm syndrome in critically ill patients. By expanding into emerging therapeutic areas and market segments, apheresis device manufacturers, service providers, and healthcare facilities can diversify their product portfolios, tap into new revenue streams, and address unmet medical needs, driving innovation and growth in the dynamic field of apheresis therapy.
Among the segments in the Apheresis Market, the Plasmapheresis segment is experiencing the fastest growth. This growth can be attributed to several factors driving the demand for plasmapheresis procedures. Firstly, there's an increasing demand for plasma-derived therapies in the treatment of various medical conditions, including autoimmune disorders, hematological disorders, and neurological disorders. Plasmapheresis plays a crucial role in the collection of plasma for the production of plasma-derived products such as immunoglobulins, albumin, and clotting factors, which are essential for the management of these conditions. Additionally, advancements in plasmapheresis technology and techniques have enhanced the efficiency, safety, and accessibility of plasma collection procedures, further driving the adoption of plasmapheresis in clinical practice. Furthermore, the growing prevalence of autoimmune diseases, hematological disorders, and neurological conditions worldwide contributes to the increasing demand for plasmapheresis as a therapeutic intervention to manage symptoms and improve patient outcomes. As healthcare providers and patients recognize the clinical benefits of plasma-derived therapies and the importance of plasmapheresis in their production, the Plasmapheresis segment is expected to sustain its rapid growth trajectory in the Apheresis Market.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAsahi Kasei Corp, B. Braun SE, Baxter International, Cerus Corp, Fresenius SE & Co. KGAA, Haemonetics Corp, Kaneka Corp, Macopharma SA, Medica SPA, Otsuka Holdings Co. Ltd , Sumitomo Bakelite Company Ltd, Terumo Corp
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Asahi Kasei Corp
B. Braun SE
Baxter International
Cerus Corp
Fresenius SE & Co. KGAA
Haemonetics Corp
Kaneka Corp
Macopharma SA
Medica SPA
Otsuka Holdings Co. Ltd
Sumitomo Bakelite Company Ltd
Terumo Corp
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Apheresis Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Apheresis Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Apheresis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Apheresis Market Size Outlook, $ Million, 2021 to 2030
3.2 Apheresis Market Outlook by Type, $ Million, 2021 to 2030
3.3 Apheresis Market Outlook by Product, $ Million, 2021 to 2030
3.4 Apheresis Market Outlook by Application, $ Million, 2021 to 2030
3.5 Apheresis Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Apheresis Industry
4.2 Key Market Trends in Apheresis Industry
4.3 Potential Opportunities in Apheresis Industry
4.4 Key Challenges in Apheresis Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Apheresis Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Apheresis Market Outlook by Segments
7.1 Apheresis Market Outlook by Segments, $ Million, 2021- 2030
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
8 North America Apheresis Market Analysis and Outlook To 2030
8.1 Introduction to North America Apheresis Markets in 2024
8.2 North America Apheresis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Apheresis Market size Outlook by Segments, 2021-2030
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
9 Europe Apheresis Market Analysis and Outlook To 2030
9.1 Introduction to Europe Apheresis Markets in 2024
9.2 Europe Apheresis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Apheresis Market Size Outlook by Segments, 2021-2030
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
10 Asia Pacific Apheresis Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Apheresis Markets in 2024
10.2 Asia Pacific Apheresis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Apheresis Market size Outlook by Segments, 2021-2030
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
11 South America Apheresis Market Analysis and Outlook To 2030
11.1 Introduction to South America Apheresis Markets in 2024
11.2 South America Apheresis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Apheresis Market size Outlook by Segments, 2021-2030
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
12 Middle East and Africa Apheresis Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Apheresis Markets in 2024
12.2 Middle East and Africa Apheresis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Apheresis Market size Outlook by Segments, 2021-2030
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Asahi Kasei Corp
B. Braun SE
Baxter International
Cerus Corp
Fresenius SE & Co. KGAA
Haemonetics Corp
Kaneka Corp
Macopharma SA
Medica SPA
Otsuka Holdings Co. Ltd
Sumitomo Bakelite Company Ltd
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Devices
Disposables
By Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Others
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Apheresis Market is one of the lucrative growth markets, poised to register a 7.8% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Asahi Kasei Corp, B. Braun SE, Baxter International, Cerus Corp, Fresenius SE & Co. KGAA, Haemonetics Corp, Kaneka Corp, Macopharma SA, Medica SPA, Otsuka Holdings Co. Ltd , Sumitomo Bakelite Company Ltd, Terumo Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume